We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Prostate Cancer "Super Responders" Live for 2 Years on Immunotherapy

News   Nov 28, 2019 | Original story from ICR

 
Prostate Cancer "Super Responders" Live for 2 Years on Immunotherapy
 
 
 

RELATED ARTICLES

Monoclonal Antibody To Prevent Malaria Enters Human Trials

News

A Phase 1 clinical trial testing the safety and effectiveness of a monoclonal antibody against malaria has begun enrolling healthy adult volunteers.

READ MORE

Gene Therapy for Duchenne Muscular Dystrophy Successful in Pigs

News

An interdisciplinary Munich research team led by scientists from TUM has for the first time succeeded in correcting the mutated dystrophin gene in living pigs. In order to cut the defective gene sequence from the DNA of the animals' muscle and heart cells, the researchers modified the Crispr-Cas9 gene scissors.

READ MORE

Metabolic Vulnerability Could Inspire New Pancreatic Cancer Treatments

News

Researchers have identified a new vulnerability in pancreatic cancer, which may provide a potential strategy for combating one of the most treatment-resistant malignancies.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE